DGX Quest Diagnostics Incorporated Common Stock
$240.56
मूल्य · अग 21, 2026
मौलिकता इस प्रकार है जुल 23, 2026
52W रेंज
$171–$246
93% of range
विश्लेषक रेटिंग
HOLD
23 analysts
मूल्य लक्ष्य
$246
+2% upside
P/E (TTM)
27.7
ROE
14.2%
शुद्ध लाभ मार्जिन
9.0%
Quest Diagnostics Incorporated Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
और पढ़ें
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.
History
1960–1995
Originally founded as Metropolitan Pathology Laboratory, Inc. in 1967 by Paul A. Brown, MD, the clinical laboratory underwent a variety of name changes. In 1969, the company's name changed to MetPath, Inc. with headquarters in Teaneck, New Jersey. By 1982, MetPath was acquired by what was then known as Corning Glass Works and was subsequently renamed Corning Clinical Laboratories.
1996–2000
On December 31, 1996, Quest Diagnostics became an independent company as a spin-off from Corning. Kenneth W. Freeman was appointed as CEO during this transition. Over the next year, Quest acquired a clinical laboratory division of Branford, Connecticut–based Diagnostic Medical Laboratory, Inc. (DML). Two years later in 1999, Quest added SmithKline Beecham Clinical Laboratories to their subsidiaries; which includes a joint venture ownership with CompuNet Clinical Laboratory. The purchase of SmithKline Beecham also included the lab's medical sample transport airline (ICAO: LBQ, call sign: LABQUEST) originally founded in 1988.
In 1997, Quest and Banner Health formed a joint venture creating the Arizona based Sonora Quest laboratory, a business unit of Laboratory Sciences of Arizona. This entity represents the operations of Quest Diagnostics in the Arizona regional market.
2001–2015
From May 2004 to April 2012, Surya Mohapatra served as the company's President and CEO. In 2007 Quest acquired diagnostic testing equipment company AmeriPath. In response to Mohapatra's resignation after eight years with Quest, former Philips Healthcare CEO Stephen Rusckowski was appointed. Under Rusckowski, Quest Diagnostics teamed up with central New England's largest health care system, UMass Memorial Health Care, to purchase its clinical outreach laboratory.
2016–present
In 2016, Quest collaborated with Safeway to bring testing services to twelve of its stores in California, Maryland, Virginia, Texas and Colorado.
By the end of 2017, Quest, in partnership with Walmart, incorporated laboratory testing in about 15 of their locations in Texas and Florida.
In May 2018, the company announced it will become an in-network laboratory provider to UnitedHealthcare starting in 2019, providing access to 48 million plan members.
In September 2018, Quest moved its headquarters from Madison, where it was located since 2007, to Secaucus, New Jersey.
In November 2018, Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing from home.
In March 2020, the company launched a COVID-19 testing service. As of July 2020, Quest had performed more than 9.2 million COVID-19 molecular tests and 2.8 million serology tests.
In April 2024, Quest has added a new blood screening to their AD-Detect product line. This test will analyze the blood for a specific Alzheimer's protein, pTau-217.
In February 2025, Quest acquired select assets of Fresenius Medical Care's Spectra laboratories. Under a separate agreement, Quest now offers clinical testing and lab services related to dialysis and end-stage kidney disease.
Acquisitions
Partnerships
2005: Forms a strategic alliance with Ciphergen Biosystems to commercialize novel proteomic tests.
Controversies
Quest Diagnostics set a record in April 2009 when it paid $302 million to the government to settle a Medicare fraud case alleging the company sold faulty medical testing kits. It was the largest qui tam (whistleblower) settlement paid by a medical laboratory for manufacturing and distributing a faulty product. In May 2011, Quest paid $241 million to the state of California to settle a False Claims Act case that alleged the company had overcharged Medi-Cal, the state's Medicaid program, and provided illegal kickbacks as incentives for healthcare providers to use Quest labs.
In 2018, Quest Diagnostics was among a number of U.S.–based laboratories linked to inaccuracies of over 200 women's cervical smear tests for CervicalCheck, Ireland's national screening program. Audits of the testing performed by Quest (and another subcontractor, Clinical Pathology Laboratories, Inc. of Austin, Texas) showed a high rate of errors in analysis of samples which led to lawsuits and a government inquiry. Quest and the Irish government continue to settle the resulting lawsuits.
On June 3, 2019, Quest announced that American Medical Collection Agency (AMCA), a billing collections service provider, had informed Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal information AMCA received from various entities, including from Quest. AMCA provides billing collections services to Optum360, which in turn is a Quest contractor. AMCA later went bankrupt after the breach.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
DGX स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$240.56
मार्केट कैप
$26.70B
P/E (TTM)
27.7
EPS (TTM)
$8.75
राजस्व (TTM)
$11.04B
लाभांश प्रतिफल
1.3%
ROE
14.2%
D/E ऋण/इक्विटी
0.8
52W रेंज
$171 – $246
DGX स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
Configure
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व और शुद्ध आय
$11.04B
2016-12-31
→
2025-12-31
EPS
$8.75
2016-12-31
→
2025-12-31
फ्री कैश फ्लो
$1.36B
2016-12-31
→
2025-12-31
मार्जिन
9.0%
2016-12-31
→
2020-12-31
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
मेट्रिक
5Y रुझान
DGX
सहकर्मी माध्यिका
P/E (TTM)
27.7
26.5
P/S (TTM)
2.4
2.0
P/B
3.7
4.9
EV / EBITDA
15.0
—
Price / FCF (मूल्य / FCF)
19.6
—
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
मेट्रिक
5Y रुझान
DGX
सहकर्मी माध्यिका
Operating Margin (परिचालन मार्जिन)
14.1%
—
Net Profit Margin (शुद्ध लाभ मार्जिन)
9.0%
4.0%
ROA
6.1%
5.0%
ROE
14.2%
15.2%
ROIC
9.2%
—
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
मेट्रिक
5Y रुझान
DGX
सहकर्मी माध्यिका
Debt / Equity (ऋण / इक्विटी)
0.8
—
Current Ratio (वर्तमान अनुपात)
1.0
1.6
Quick Ratio (त्वरित अनुपात)
0.8
—
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
मेट्रिक
5Y रुझान
DGX
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
11.8%
—
Revenue CAGR 3Y (राजस्व CAGR 3Y)
3.7%
—
Revenue CAGR 5Y (राजस्व CAGR 5Y)
3.2%
—
EPS YoY
13.8%
—
Net Income YoY (शुद्ध आय YoY)
13.9%
—
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
मेट्रिक
5Y रुझान
DGX
सहकर्मी माध्यिका
Payout Ratio (भुगतान अनुपात)
35.6%
—
लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR
लाभांश यील्ड
1.3%
भुगतान अनुपात
35.6%
5Y लाभांश CAGR
—
| एक्स-डेट | राशि |
|---|---|
| 8 जुलाई 2026 | $0.8600 |
| 6 अप्रैल 2026 | $0.8600 |
| 13 जनवरी 2026 | $0.8000 |
| 3 अक्टूबर 2025 | $0.8000 |
| 7 जुलाई 2025 | $0.8000 |
| 7 अप्रैल 2025 | $0.8000 |
| 14 जनवरी 2025 | $0.7500 |
| 4 अक्टूबर 2024 | $0.7500 |
| 8 जुलाई 2024 | $0.7500 |
| 5 अप्रैल 2024 | $0.7500 |
| 16 जनवरी 2024 | $0.7100 |
| 5 अक्टूबर 2023 | $0.7100 |
| 10 जुलाई 2023 | $0.7100 |
| 6 अप्रैल 2023 | $0.7100 |
| 17 जनवरी 2023 | $0.6600 |
| 3 अक्टूबर 2022 | $0.6600 |
| 5 जुलाई 2022 | $0.6600 |
| 5 अप्रैल 2022 | $0.6600 |
| 18 जनवरी 2022 | $0.6200 |
| 4 अक्टूबर 2021 | $0.6200 |
DGX विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
खरीदें
23 विश्लेषक
- मजबूत खरीद 6 26.1%
- खरीदें 7 30.4%
- होल्ड 10 43.5%
- बेचें 0 0.0%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
15 विश्लेषक · 2026-08-16
मध्यिका
$250.00
अभी
$240.56
निम्न
$204.00
उच्च
$265.00
मध्यिका लक्ष्य
$250.00
+3.9%
माध्य लक्ष्य
$245.87
+2.2%
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
0.09%
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $3.12 | $2.85 | 0.27% |
| 31 मार्च 2026 | $2.50 | $2.37 | 0.13% |
| 31 दिसमबर 2025 | $2.42 | $2.38 | 0.04% |
| 30 सितमबर 2025 | $2.60 | $2.53 | 0.07% |
| 30 जून 2025 | $2.62 | $2.60 | 0.02% |
| 31 मार्च 2025 | $2.21 | $2.17 | 0.04% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 17
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Cost of Revenue | $7.37B | $6.63B | $6.20B | $6.45B | $6.58B | $5.80B | $5.04B | $4.93B | $4.72B | $4.62B | $4.66B | $4.64B | |
| Gross Profit | · | · | · | · | · | $3.63B | $2.69B | $2.60B | $2.68B | $2.90B | $2.84B | $2.80B | |
| SG&A Expense | $1.97B | $1.77B | $1.64B | $1.87B | $1.73B | $1.55B | $1.46B | $1.42B | $1.44B | $1.38B | $1.68B | $1.73B | |
| Operating Expenses | $9.48B | $8.53B | $7.99B | $8.46B | $8.41B | $7.47B | $6.50B | $6.43B | $6.24B | $5.94B | $6.09B | $6.45B | |
| Operating Income | $1.56B | $1.35B | $1.26B | $1.43B | $2.38B | $1.97B | $1.23B | $1.10B | $1.17B | $1.28B | $1.40B | $983M | |
| Interest Expense | · | · | $163M | $148M | $152M | $166M | $180M | $169M | $153M | $144M | $154M | $167M | |
| Interest Income | $13M | $25M | $11M | $10M | $1M | $3M | $5M | $2M | $2M | $1M | $1M | $3M | |
| Other Non-op | $26M | $30M | $20M | $-55M | $369M | $76M | $20M | $-8M | $16M | $-48M | $-143M | $4M | |
| Pretax Income | $1.32B | $1.18B | $1.13B | $1.24B | $2.60B | $1.88B | $1.08B | $926M | $1.03B | $1.09B | $1.10B | $823M | |
| Income Tax | $314M | $273M | $248M | $264M | $597M | $460M | $247M | $182M | $241M | $429M | $373M | $262M | |
| Net Income | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| EPS (Basic) | $8.87 | $7.78 | $7.59 | $8.10 | $15.85 | $10.62 | $6.36 | $5.39 | $5.63 | $4.58 | $4.92 | $3.83 | |
| EPS (Diluted) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 | $4.87 | $3.81 | |
| Shares (Basic) | 111,000,000 | 111,000,000 | 112,000,000 | 116,000,000 | 125,000,000 | 134,000,000 | 134,000,000 | 136,000,000 | 137,000,000 | 140,000,000 | 144,000,000 | 145,000,000 | |
| Shares (Diluted) | 113,000,000 | 113,000,000 | 113,000,000 | 118,000,000 | 128,000,000 | 136,000,000 | 136,000,000 | 139,000,000 | 140,000,000 | 142,000,000 | 145,000,000 | 145,000,000 | |
| EBITDA | $2.13B | $1.84B | $1.70B | $1.86B | $2.79B | $2.33B | $1.56B | $1.41B | $1.44B | $1.53B | $1.70B | $1.30B |
बैलेंस शीट 27
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $420M | $549M | $686M | $315M | $872M | $1.16B | $1.19B | $135M | $137M | $359M | $133M | $192M | |
| Receivables | $1.41B | $1.30B | $1.21B | $1.20B | $1.44B | $1.52B | $1.06B | $1.01B | $924M | $926M | $901M | $932M | |
| Inventory | $189M | $188M | $190M | $192M | $208M | $223M | $123M | $99M | $95M | $82M | $84M | $110M | |
| Prepaid Expense | $361M | $351M | $286M | $196M | $223M | $157M | $112M | $144M | $150M | $155M | $207M | $186M | |
| Current Assets | $2.38B | $2.39B | $2.37B | $1.90B | $2.74B | $3.06B | $2.49B | $1.39B | $1.31B | $1.53B | $1.50B | $1.60B | |
| PP&E (Net) | $2.20B | $2.11B | $1.82B | $1.77B | $1.71B | $1.63B | $1.45B | $1.29B | $1.15B | $1.03B | $925M | $933M | |
| PP&E (Gross) | $6.18B | $5.77B | $5.23B | $5.10B | $4.79B | $4.62B | $4.23B | $3.97B | $3.67B | $3.43B | $3.23B | $3.13B | |
| Accum. Depreciation | $3.97B | $3.66B | $3.42B | $3.34B | $3.09B | $2.99B | $2.78B | $2.68B | $2.53B | $2.40B | $2.31B | $2.19B | |
| Goodwill | $8.95B | $8.86B | $7.73B | $7.22B | $7.09B | $6.87B | $6.62B | $6.56B | $6.33B | $6.00B | $5.91B | $6.03B | |
| Intangibles | $1.64B | $1.76B | $1.17B | $1.09B | $1.17B | $1.17B | $1.12B | $1.21B | $1.12B | $949M | $984M | $1.07B | |
| Other Non-current Assets | $270M | $255M | $198M | $144M | $163M | $176M | $160M | $119M | $136M | $148M | $174M | $172M | |
| Total Assets | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Accounts Payable | $1.60B | $1.39B | $1.36B | $1.40B | $1.60B | $1.63B | $1.04B | $1.02B | $1.02B | $975M | $1.01B | $1.19B | |
| Accrued Liabilities | $338M | $306M | $287M | $392M | $460M | $356M | $223M | $274M | $246M | $254M | $257M | $277M | |
| Current Liabilities | $2.28B | $2.17B | $1.81B | $1.55B | $1.75B | $1.78B | $1.99B | $1.49B | $1.06B | $981M | $1.17B | $1.71B | |
| Capital Leases | $537M | $535M | $503M | $489M | $494M | $499M | $413M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $264M | $243M | $170M | $191M | $157M | $204M | |
| Other Non-current Liabilities | $957M | $938M | $876M | $812M | $792M | $847M | $711M | $745M | $663M | $654M | $514M | $594M | |
| Long-term Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.74B | |
| Total Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.76B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Retained Earnings | $9.99B | $9.36B | $8.82B | $8.29B | $7.65B | $9.30B | $8.17B | $7.60B | $7.14B | $6.61B | $6.20B | $5.72B | |
| Treasury Stock | $5.18B | $4.86B | $4.83B | $4.67B | $3.45B | $5.37B | $5.22B | $5.00B | $4.78B | $4.46B | $3.96B | $3.81B | |
| AOCI | $-27M | $-88M | $-14M | $-21M | $-14M | $-21M | $-39M | $-59M | $-48M | $-72M | $-38M | $-27M | |
| Stockholders' Equity | $7.17B | $6.78B | $6.31B | $5.89B | $6.44B | $6.76B | $5.64B | $5.22B | $4.92B | $4.63B | $4.68B | $4.30B | |
| Liabilities + Equity | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Shares Outstanding | 110,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 119,000,000 | 133,000,000 | 133,000,000 | 135,000,000 | 135,000,000 | 137,000,000 | 143,000,000 | 144,000,000 |
नकदी प्रवाह 17
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $570M | $493M | $439M | $437M | $408M | $361M | $329M | $309M | $270M | $249M | $304M | $314M | |
| Stock-based Comp | $88M | $88M | $77M | $77M | $79M | $97M | $56M | $61M | $79M | $69M | $52M | $51M | |
| Deferred Tax | $105M | $13M | $-49M | $1M | $-57M | $85M | $15M | $73M | $9M | $37M | $112M | $23M | |
| Amort. of Intangibles | $154M | $127M | $108M | $120M | $103M | $103M | $96M | $90M | $74M | $72M | $81M | $94M | |
| Restructuring | · | · | · | $55M | $13M | $14M | $-3M | $49M | $30M | $11M | $39M | $43M | |
| Other Non-cash | $131M | $-131M | $-49M | $257M | $-192M | $31M | $-15M | $21M | $45M | $69M | $-367M | $-6M | |
| Operating Cash Flow | $1.89B | $1.33B | $1.27B | $1.72B | $2.23B | $2.00B | $1.24B | $1.20B | $1.18B | $1.12B | $821M | $944M | |
| CapEx | $527M | $425M | $408M | $404M | $403M | $418M | $400M | $383M | $252M | $293M | $263M | $308M | |
| Investing Cash Flow | $-631M | $-2.55B | $-1.06B | $-543M | $21M | $-772M | $-411M | $-801M | $-830M | $-127M | $-362M | $-1.02B | |
| Stock Repurchased | $450M | $151M | $275M | $1.41B | $2.20B | $325M | $353M | $322M | $465M | $590M | $224M | $132M | |
| Net Stock Activity | $-450M | $-151M | $-275M | $-1.41B | $-2.20B | $-325M | $-353M | $-322M | $-465M | $-590M | $-224M | $-132M | |
| Dividends Paid | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M | |
| Financing Cash Flow | $-1.39B | $1.08B | $160M | $-1.73B | $-2.54B | $-1.27B | $225M | $-401M | $-592M | $-738M | $-518M | $86M | |
| Net Change in Cash | $-129M | $-137M | $371M | $-557M | $-286M | · | · | · | $-222M | $226M | $-59M | $5M | |
| Taxes Paid | $169M | $256M | $317M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.36B | $909M | $864M | $1.31B | $1.83B | $1.59B | $843M | $817M | $923M | $776M | $547M | $630M | |
| Levered FCF | · | · | $737M | $1.20B | $1.71B | $1.46B | $704M | $681M | $806M | $689M | · | · |
लाभप्रदता 8
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 38.5% | 34.8% | 34.6% | 38.8% | 38.6% | 37.9% | 37.6% | |
| Operating Margin | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% | 15.9% | 14.6% | 15.1% | 17.0% | 18.7% | 13.2% | |
| Net Margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% | 11.1% | 9.8% | 10.0% | 8.6% | 9.5% | 7.5% | |
| Pretax Margin | 11.9% | 11.9% | 12.2% | 12.5% | 24.1% | 20.0% | 13.9% | 12.3% | 13.4% | 14.4% | 14.7% | · | |
| EBITDA Margin | 19.3% | 18.6% | 18.4% | 18.9% | 25.9% | 24.7% | 20.2% | 18.7% | 18.6% | 20.3% | 22.7% | 17.4% | |
| ROA | 6.1% | 5.8% | 6.4% | 7.1% | 14.4% | 10.7% | 7.2% | 6.8% | 7.5% | 6.4% | 7.1% | 5.9% | |
| ROE | 14.2% | 13.3% | 14.0% | 15.3% | 30.2% | 23.1% | 15.8% | 14.5% | 16.2% | 13.9% | 15.8% | 13.5% | |
| ROIC | 9.2% | 8.0% | 8.9% | 11.4% | 17.5% | 13.8% | 9.1% | 9.7% | 10.2% | 9.2% | 11.1% | · |
तरलता और शोधन क्षमता 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 | 1.7 | 1.3 | 0.9 | 1.2 | 1.6 | 1.3 | 0.9 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 | 1.5 | 1.1 | 0.8 | 1.0 | 1.3 | 0.9 | 0.7 | |
| Debt / Equity | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 | 0.6 | 0.8 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.8 | |
| Interest Coverage | · | · | 7.7 | 9.6 | 15.7 | 11.9 | 6.8 | 6.5 | 7.6 | 8.9 | · | · |
दक्षता 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | |
| Inventory Turnover | 39.1 | 35.1 | 32.5 | 32.2 | 30.5 | 33.5 | 45.4 | 50.8 | 53.3 | 55.6 | 48.0 | 46.1 | |
| Receivables Turnover | 8.1 | 7.9 | 7.7 | 7.5 | 7.3 | 7.3 | 7.4 | 7.8 | 8.3 | 8.2 | 8.2 | 8.3 |
विकास दरें 10
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 6.7% | -6.4% | -8.4% | 14.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 3.7% | -2.9% | -0.66% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 13.8% | 2.7% | -6.0% | -48.8% | 48.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 3.2% | -20.9% | -10.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 13.9% | 2.0% | -9.7% | -52.6% | 39.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.6% | -24.1% | -15.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -7.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 3.5% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Net Income TTM | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| Market Cap | $19.09B | $16.75B | $15.30B | $17.36B | $20.59B | $15.85B | $14.20B | $11.24B | $13.30B | $12.59B | $10.17B | $9.66B | |
| Enterprise Value | $24.34B | $22.41B | $19.33B | $21.03B | $23.73B | $18.71B | $17.78B | $15.00B | $16.94B | $15.97B | $13.69B | $13.23B | |
| P/E | 19.8 | 19.6 | 18.4 | 19.6 | 11.1 | 11.4 | 17.0 | 15.7 | 17.9 | 20.4 | 14.6 | 17.6 | |
| P/S | 1.7 | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.8 | 1.5 | 1.8 | 1.7 | 1.4 | 1.3 | |
| P/B | 2.7 | 2.5 | 2.4 | 2.9 | 3.2 | 2.3 | 2.5 | 2.2 | 2.7 | 2.7 | 2.2 | 2.2 | |
| P / Cash Flow | 10.1 | 12.6 | 12.0 | 10.1 | 9.2 | 7.9 | 11.4 | 9.4 | 11.3 | 11.8 | 12.6 | 10.3 | |
| P / FCF | 14.0 | 18.4 | 17.7 | 13.2 | 11.3 | 10.0 | 16.8 | 13.8 | 14.4 | 16.2 | 18.6 | 15.3 | |
| EV / EBITDA | 11.4 | 12.2 | 11.4 | 11.3 | 8.5 | 8.0 | 11.4 | 10.6 | 11.8 | 10.5 | 8.0 | 10.2 | |
| EV / FCF | 17.9 | 24.7 | 22.4 | 16.0 | 13.0 | 11.8 | 21.1 | 18.4 | 18.4 | 20.6 | 25.0 | 21.0 | |
| EV / Revenue | 2.2 | 2.3 | 2.1 | 2.1 | 2.2 | 2.0 | 2.3 | 2.0 | 2.3 | 2.2 | 1.8 | 1.8 | |
| Dividend Yield | 1.8% | 2.0% | 2.1% | 1.8% | 1.5% | 1.9% | 2.0% | 2.4% | 1.9% | 1.8% | 2.1% | 1.9% | |
| Earnings Yield | 5.0% | 5.1% | 5.4% | 5.1% | 9.0% | 8.8% | 5.9% | 6.3% | 5.6% | 4.9% | 6.9% | 5.7% | |
| Payout Ratio | 35.6% | 38.0% | 36.8% | 32.2% | 15.5% | 20.8% | 33.3% | 36.1% | 32.0% | 34.6% | 29.9% | 33.6% | |
| Annual Payout | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M |
आय विवरण 16
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04B | $2.90B | $2.81B | $2.82B | $2.76B | $2.65B | $2.62B | $2.49B | $2.40B | $2.37B | $2.29B | $2.29B | $2.34B | $2.33B | $2.33B | $2.49B | |
| Cost of Revenue | $2.02B | $1.95B | $1.90B | $1.87B | $1.82B | $1.79B | $1.76B | $1.68B | $1.59B | $1.59B | $1.55B | $1.54B | $1.55B | $1.56B | $1.57B | $1.62B | |
| SG&A Expense | $529M | $504M | $504M | $501M | $486M | $476M | $466M | $448M | $416M | $440M | $407M | $380M | $416M | $439M | $563M | $464M | |
| Operating Expenses | $2.58B | $2.50B | $2.42B | $2.43B | $2.32B | $2.31B | $2.26B | $2.16B | $2.04B | $2.07B | $2.02B | $1.95B | $1.99B | $2.03B | $2.20B | $2.09B | |
| Operating Income | $459M | $399M | $386M | $386M | $438M | $346M | $361M | $330M | $355M | $300M | $267M | $342M | $348M | $305M | $135M | $392M | |
| Interest Expense | · | · | · | · | · | · | · | · | $47M | $49M | · | $41M | $39M | $37M | · | $37M | |
| Interest Income | $5M | $2M | $3M | $3M | $2M | $5M | $7M | $9M | $3M | $6M | $6M | $1M | $2M | $2M | $4M | $4M | |
| Other Non-op | $16M | $-2M | $8M | $8M | $13M | $-3M | $3M | $15M | $3M | $9M | $10M | $-3M | $6M | $7M | $6M | $-8M | |
| Pretax Income | $412M | $334M | $330M | $328M | $384M | $276M | $299M | $296M | $314M | $266M | $237M | $299M | $317M | $277M | $109M | $351M | |
| Income Tax | $88M | $74M | $81M | $77M | $97M | $59M | $68M | $65M | $74M | $66M | $40M | $68M | $75M | $65M | $-4M | $81M | |
| Net Income | $320M | $252M | $245M | $245M | $282M | $220M | $222M | $226M | $229M | $194M | $192M | $225M | $235M | $202M | $101M | $256M | |
| EPS (Basic) | $2.88 | $2.27 | $2.21 | $2.18 | $2.51 | $1.97 | $1.98 | $2.01 | $2.05 | $1.74 | $1.72 | $1.99 | $2.08 | $1.80 | $0.93 | $2.20 | |
| EPS (Diluted) | $2.84 | $2.24 | $2.18 | $2.16 | $2.47 | $1.94 | $1.95 | $1.99 | $2.03 | $1.72 | $1.70 | $1.96 | $2.05 | $1.78 | $0.92 | $2.17 | |
| Shares (Basic) | 111,000,000 | 110,000,000 | -224,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | -223,000,000 | 112,000,000 | 111,000,000 | 111,000,000 | -224,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | -236,000,000 | 116,000,000 | |
| Shares (Diluted) | 112,000,000 | 112,000,000 | -226,000,000 | 113,000,000 | 113,000,000 | 113,000,000 | -224,000,000 | 113,000,000 | 112,000,000 | 112,000,000 | -228,000,000 | 114,000,000 | 114,000,000 | 113,000,000 | -240,000,000 | 118,000,000 | |
| EBITDA | $605M | $546M | · | $528M | $581M | $486M | · | $455M | $472M | $416M | · | $453M | $460M | $412M | · | $500M |
बैलेंस शीट 26
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $626M | $393M | $420M | $432M | $319M | $188M | $549M | $764M | $271M | $474M | · | $143M | $126M | $175M | · | $700M | |
| Receivables | $1.67B | $1.59B | $1.41B | $1.46B | $1.42B | $1.40B | $1.30B | $1.38B | $1.32B | $1.32B | · | $1.28B | $1.24B | $1.25B | · | $1.28B | |
| Inventory | $233M | $225M | $189M | $186M | $187M | $189M | $188M | $184M | $182M | $181M | · | $184M | $184M | $190M | · | $183M | |
| Prepaid Expense | $319M | $361M | $361M | $333M | $273M | $294M | $351M | $299M | $245M | $251M | · | $207M | $188M | $195M | · | $171M | |
| Current Assets | $2.84B | $2.57B | $2.38B | $2.41B | $2.20B | $2.08B | $2.39B | $2.62B | $2.02B | $2.23B | · | $1.81B | $1.73B | $1.81B | · | $2.33B | |
| PP&E (Net) | $2.22B | $2.19B | $2.20B | $2.15B | $2.12B | $2.10B | $2.11B | $2.09B | $1.83B | $1.81B | · | $1.83B | $1.81B | $1.79B | · | $1.71B | |
| PP&E (Gross) | · | · | $6.18B | · | · | · | $5.77B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.97B | · | · | · | $3.66B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $9.11B | $9.12B | $8.95B | $8.90B | $8.88B | $8.85B | $8.86B | $8.61B | $7.88B | $7.83B | $7.73B | $7.73B | $7.73B | $7.24B | $7.22B | $7.19B | |
| Intangibles | $1.67B | $1.72B | $1.64B | $1.66B | $1.71B | $1.73B | $1.76B | $1.72B | $1.20B | $1.19B | · | $1.22B | $1.25B | $1.08B | · | $1.11B | |
| Other Non-current Assets | $277M | $256M | $270M | $296M | $271M | $260M | $255M | $272M | $216M | $182M | · | $149M | $152M | $150M | · | $132M | |
| Total Assets | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | $13.22B | |
| Accounts Payable | $1.60B | $1.50B | $1.60B | $1.46B | $1.35B | $1.27B | $1.39B | $1.31B | $1.25B | $1.24B | · | $1.16B | $1.20B | $1.20B | · | $1.45B | |
| Accrued Liabilities | · | · | $338M | · | · | · | $306M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $1.79B | $2.18B | $2.28B | $2.13B | $2.02B | $1.44B | $2.17B | $2.09B | $2.01B | $2.30B | · | $1.62B | $1.88B | $1.35B | · | $1.60B | |
| Capital Leases | $561M | $574M | $537M | $534M | $540M | $538M | $535M | $543M | $507M | $489M | · | $505M | $508M | $490M | · | $505M | |
| Other Non-current Liabilities | $1.06B | $1.02B | $957M | $982M | $890M | $917M | $938M | $891M | $811M | $817M | · | $874M | $901M | $809M | · | $787M | |
| Long-term Debt | $5.64B | · | $5.67B | · | · | · | $6.22B | $6.25B | · | · | · | · | · | · | · | · | |
| Total Debt | $5.64B | $503M | · | $504M | $504M | $1M | · | $6.25B | $606M | $906M | · | $304M | $518M | $2M | · | $2M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Retained Earnings | $10.37B | $10.15B | $9.99B | $9.84B | $9.68B | $9.49B | $9.36B | $9.22B | $9.08B | $8.94B | · | $8.71B | $8.57B | $8.41B | · | $8.26B | |
| Treasury Stock | $5.17B | $5.09B | $5.18B | $4.90B | $4.77B | $4.79B | $4.86B | $4.73B | $4.76B | $4.78B | · | $4.57B | $4.59B | $4.61B | · | $4.27B | |
| AOCI | $-62M | $-43M | $-27M | $-40M | $-16M | $-83M | $-88M | $-15M | $-19M | $-16M | · | $-20M | $-16M | $-18M | · | $-31M | |
| Stockholders' Equity | $7.52B | $7.37B | $7.17B | $7.26B | $7.23B | $6.93B | $6.78B | $6.81B | $6.62B | $6.43B | · | $6.42B | $6.25B | $6.05B | · | $6.24B | |
| Liabilities + Equity | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | $13.22B | |
| Shares Outstanding | 110,000,000 | 111,000,000 | 110,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 112,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 114,000,000 |
नकदी प्रवाह 16
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $146M | $147M | $145M | $142M | $143M | $140M | $135M | $125M | $117M | $116M | $109M | $111M | $112M | $107M | $116M | $108M | |
| Stock-based Comp | $23M | $20M | $25M | $20M | $21M | $22M | $27M | $19M | $20M | $22M | $19M | $18M | $16M | $24M | $22M | $18M | |
| Deferred Tax | $-2M | $48M | $-13M | $110M | $1M | $7M | $34M | $15M | $-18M | $-18M | $-10M | $-23M | $-12M | $-4M | $-44M | $65M | |
| Amort. of Intangibles | $38M | $37M | $37M | $39M | $39M | $39M | $37M | $32M | $29M | $29M | $27M | $27M | $28M | $26M | $39M | $27M | |
| Restructuring | · | · | · | $6M | $1M | · | · | $7M | $8M | · | · | $1M | $1M | · | · | · | |
| Other Non-cash | · | $-189M | · | · | · | $-75M | · | · | · | $-160M | · | · | · | $-235M | · | · | |
| Operating Cash Flow | $597M | $278M | $465M | $563M | $544M | $314M | $464M | $356M | $360M | $154M | $527M | $207M | $444M | $94M | $334M | $502M | |
| CapEx | $138M | $114M | $158M | $144M | $108M | $117M | $123M | $106M | $92M | $104M | $72M | $105M | $104M | $127M | $147M | $118M | |
| Investing Cash Flow | $-134M | $-152M | $-191M | $-201M | $-124M | $-115M | $-502M | $-1.63B | $-200M | $-213M | $-114M | $-107M | $-682M | $-158M | $-174M | $-118M | |
| Stock Repurchased | · | · | $300M | $150M | · | · | $151M | · | · | · | $275M | $0 | $0 | $0 | $461M | $374M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $96M | $88M | $90M | $89M | $90M | $84M | $84M | $84M | $84M | $79M | $80M | $80M | $80M | $74M | $75M | $78M | |
| Financing Cash Flow | $-229M | $-152M | $-287M | $-247M | $-293M | $-561M | $-170M | $1.77B | $-363M | $-153M | $130M | $-83M | $189M | $-76M | $-545M | $-474M | |
| Net Change in Cash | $233M | $-27M | $-12M | $113M | $131M | $-361M | $-215M | $493M | $-203M | $-212M | $543M | $17M | $-49M | $-140M | $-385M | $-90M | |
| Free Cash Flow | · | $164M | · | · | · | $197M | · | · | · | $50M | · | · | · | $-33M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $13M | · | · | · | $-61M | · | · |
लाभप्रदता 7
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.1% | 13.8% | · | 13.7% | 15.9% | 13.1% | · | 13.3% | 14.8% | 12.7% | · | 14.9% | 14.9% | 13.1% | · | 15.8% | |
| Net Margin | 10.5% | 8.7% | · | 8.7% | 10.2% | 8.3% | · | 9.1% | 9.6% | 8.2% | · | 9.8% | 10.1% | 8.7% | · | 10.3% | |
| Pretax Margin | 13.5% | 11.5% | · | 11.7% | 13.9% | 10.4% | · | 11.9% | 13.1% | 11.2% | · | 13.0% | 13.6% | 11.9% | · | 14.1% | |
| EBITDA Margin | 19.9% | 18.9% | · | 18.8% | 21.0% | 18.3% | · | 18.3% | 19.7% | 17.6% | · | 19.7% | 19.7% | 17.7% | · | 20.1% | |
| ROA | 1.9% | 1.6% | · | 1.5% | 1.9% | 1.5% | · | 1.5% | 1.7% | 1.5% | · | 1.7% | 1.8% | 1.5% | · | 1.9% | |
| ROE | 4.3% | 3.5% | · | 3.5% | 4.1% | 3.3% | · | 3.4% | 3.6% | 3.1% | · | 3.5% | 3.7% | 3.2% | · | 4.0% | |
| ROIC | 2.7% | 4.0% | · | 3.8% | 4.2% | 3.9% | · | 2.0% | 3.8% | 3.1% | · | 3.9% | 3.9% | 3.9% | · | 4.8% |
तरलता और शोधन क्षमता 5
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.2 | · | 1.1 | 1.1 | 1.4 | · | 1.3 | 1.0 | 1.0 | · | 1.1 | 0.9 | 1.3 | · | 1.5 | |
| Quick Ratio | 1.3 | 0.9 | · | 0.9 | 0.9 | 1.1 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | 0.7 | 1.1 | · | 1.2 | |
| Debt / Equity | 0.8 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.9 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.7 | · | · | · | · | · | · | 0.8 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | 7.6 | 6.1 | · | 8.3 | 8.9 | 8.2 | · | 10.6 |
दक्षता 3
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 9.6 | 9.4 | · | 10.1 | 9.9 | 9.7 | · | 9.1 | 8.7 | 8.6 | · | 8.4 | 8.3 | 8.1 | · | 8.3 | |
| Receivables Turnover | 2.0 | 1.9 | · | 2.0 | 2.0 | 1.9 | · | 1.9 | 1.9 | 1.8 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
मूल्यांकन (TTM) 14
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.52B | $11.12B | · | $10.72B | $10.30B | $9.90B | · | $9.55B | $9.40B | $9.33B | · | $9.45B | $9.61B | $9.88B | · | $10.32B | |
| Net Income TTM | $1.10B | $999M | · | $973M | $957M | $869M | · | $874M | $883M | $856M | · | $918M | $927M | $1.05B | · | $1.35B | |
| Market Cap | $23.31B | $21.75B | · | $21.15B | $20.12B | $18.95B | · | $17.39B | $15.19B | $14.78B | · | $13.65B | $15.74B | $15.85B | · | $13.99B | |
| Enterprise Value | $28.33B | $21.86B | · | $21.23B | $20.30B | $18.76B | · | $22.88B | $15.53B | $15.21B | · | $13.81B | $16.13B | $15.67B | · | $13.29B | |
| P/E | 21.8 | 22.2 | · | 22.3 | 21.3 | 22.0 | · | 20.2 | 17.6 | 17.7 | · | 15.3 | 17.7 | 16.0 | · | 11.1 | |
| P/S | 2.0 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.6 | 1.6 | · | 1.4 | 1.6 | 1.6 | · | 1.4 | |
| P/B | 3.1 | 3.0 | · | 2.9 | 2.8 | 2.7 | · | 2.6 | 2.3 | 2.3 | · | 2.1 | 2.5 | 2.6 | · | 2.2 | |
| P / Cash Flow | · | 78.3 | · | · | · | 60.4 | · | · | · | 95.9 | · | · | · | 168.6 | · | · | |
| P / FCF | · | 132.6 | · | · | · | 96.2 | · | · | · | 295.5 | · | · | · | -480.2 | · | · | |
| EV / EBITDA | 46.8 | 40.0 | · | 40.2 | 34.9 | 38.6 | · | 50.3 | 32.9 | 36.6 | · | 30.5 | 35.1 | 38.0 | · | 26.6 | |
| EV / FCF | · | 133.3 | · | · | · | 95.2 | · | · | · | 304.1 | · | · | · | -474.9 | · | · | |
| EV / Revenue | 2.5 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 2.4 | 1.7 | 1.6 | · | 1.5 | 1.7 | 1.6 | · | 1.3 | |
| Earnings Yield | 4.6% | 4.5% | · | 4.5% | 4.7% | 4.5% | · | 5.0% | 5.7% | 5.6% | · | 6.5% | 5.7% | 6.2% | · | 9.0% | |
| Payout Ratio | · | 34.9% | · | · | · | 38.2% | · | · | · | 40.7% | · | · | · | 36.6% | · | · |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B |
| परिचालन मार्जिन % | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% |
| शुद्ध आय | $992M | $871M | $854M | $946M | $2.00B |
| तनुकरणित EPS | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 |
| वर्तमान अनुपात | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 |
| त्वरित अनुपात | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $1.36B | $909M | $864M | $1.31B | $1.83B |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
📊
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 1176 फाइलर्स · $12.9B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 115 (-25 पिछली तिमाही की तुलना में) | 64 (-17 पिछली तिमाही की तुलना में) | 415 (+69 पिछली तिमाही की तुलना में) | 333 (-20 पिछली तिमाही की तुलना में) | +7.5M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1533117858 | 7233394 | 11.93% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1299474988 | 6131045 | 10.11% | शेयर |
| STATE STREET CORP | $1169252484 | 5516643 | 9.10% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $584135885 | 2767754 | 4.54% | शेयर |
| EdgePoint Investment Group Inc. | $476372038 | 2247568 | 3.71% | शेयर |
| Grantham, Mayo, Van Otterloo & Co. LLC | $400206122 | 1888207 | 3.11% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $357050202 | 1684597 | 2.78% | शेयर |
| Davis Selected Advisers | $329781509 | 1555612 | 2.57% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $311037928 | 1467506 | 2.42% | शेयर |
| NORGES BANK | $298133109 | 1406620 | 2.32% | शेयर |
| FMR LLC | $227315614 | 1072496 | 1.77% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $173422135 | 818220 | 1.35% | शेयर |
| M&G PLC | $168677800 | 795650 | 1.31% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $131756386 | 621639 | 1.03% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $122662706 | 625894 | 0.95% | शेयर |
| AMERIPRISE FINANCIAL INC | $109652758 | 517352 | 0.85% | शेयर |
| Woodline Partners LP | $102974000 | 485841 | 0.80% | शेयर |
| FIDUCIARY MANAGEMENT INC /WI/ | $102489906 | 483557 | 0.80% | शेयर |
| Artemis Investment Management LLP | $99175856 | 467921 | 0.77% | शेयर |
| CRAWFORD INVESTMENT COUNSEL INC | $97514204 | 460081 | 0.76% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $91995201 | 434042 | 0.72% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $90834224 | 428564 | 0.71% | शेयर |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $86608697 | 407302 | 0.67% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $83772178 | 395245 | 0.65% | शेयर |
| M.D. Sass, LLC | $76397960 | 360453 | 0.59% | शेयर |
| Qube Research & Technologies Ltd | $72783206 | 343398 | 0.57% | शेयर |
| MACKENZIE FINANCIAL CORP | $70641875 | 333295 | 0.55% | शेयर |
| Advisors Capital Management, LLC | $69429626 | 327575 | 0.54% | शेयर |
| Swiss National Bank | $65683305 | 309900 | 0.51% | शेयर |
| Balyasny Asset Management L.P. | $58364883 | 275371 | 0.45% | शेयर |
| Mitsubishi UFJ Asset Management Co., Ltd. | $56877630 | 268354 | 0.44% | शेयर |
| RHUMBLINE ADVISERS | $56744612 | 267727 | 0.44% | शेयर |
| BlackRock, Inc. | $55976419 | 264102 | 0.44% | शेयर |
| Sumitomo Mitsui Trust Group, Inc. | $54809634 | 258597 | 0.43% | शेयर |
| VANGUARD ASSET MANAGEMENT, Ltd | $53654295 | 253146 | 0.42% | शेयर |
| Quantinno Capital Management LP | $53607358 | 252924 | 0.42% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $53249860 | 251238 | 0.41% | शेयर |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $52211551 | 246339 | 0.41% | शेयर |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $51484139 | 242907 | 0.40% | शेयर |
| Clark Capital Management Group, Inc. | $51259362 | 241846 | 0.40% | शेयर |
| Vanguard Global Advisers, LLC | $51025267 | 240742 | 0.40% | शेयर |
| Legal & General Group Plc | $50185731 | 236781 | 0.39% | शेयर |
| FIL Ltd | $49419958 | 233168 | 0.38% | शेयर |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $49341000 | 232797 | 0.38% | शेयर |
| Eurizon Capital SGR S.p.A. | $47173414 | 222564 | 0.37% | शेयर |
| BARCLAYS PLC | $45003978 | 212333 | 0.35% | शेयर |
| PFA Pension, Forsikringsaktieselskab | $43579660 | 205613 | 0.34% | शेयर |
| Integral Health Asset Management, LLC | $42390000 | 200000 | 0.33% | शेयर |
| California Public Employees Retirement System | $41574204 | 196151 | 0.32% | शेयर |
| CONNING INC. | $39578271 | 186734 | 0.31% | शेयर |
| SEB Asset Management AB | $38766863 | 182906 | 0.30% | शेयर |
| BANK OF MONTREAL /CAN/ | $38512587 | 181706 | 0.30% | शेयर |
| GOLDMAN SACHS GROUP INC | $38322295 | 180808 | 0.30% | शेयर |
| Boston Partners | $35509632 | 167514 | 0.28% | शेयर |
| Focus Partners Wealth | $34616947 | 163327 | 0.27% | शेयर |
| STOREBRAND ASSET MANAGEMENT AS | $34117592 | 160970 | 0.27% | शेयर |
| COOKSON PEIRCE & CO INC | $32977089 | 155589 | 0.26% | शेयर |
| UBS Group AG | $32934699 | 155389 | 0.26% | शेयर |
| BRAUN STACEY ASSOCIATES INC | $32724232 | 154396 | 0.25% | शेयर |
| Willis Investment Counsel | $32110425 | 151500 | 0.25% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $31795403 | 162238 | 0.25% | शेयर |
| LPL Financial LLC | $30325576 | 143079 | 0.24% | शेयर |
| APG Asset Management N.V. | $27869580 | 150334 | 0.22% | शेयर |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $26893912 | 126888 | 0.21% | शेयर |
| &PARTNERS | $26382365 | 124363 | 0.21% | शेयर |
| JANE STREET GROUP, LLC | $25942680 | 122400 | 0.20% | कॉल ऑप्शन |
| BANK OF AMERICA CORP /DE/ | $25492499 | 120276 | 0.20% | शेयर |
| Candriam S.C.A. | $25459925 | 120238 | 0.20% | शेयर |
| Squarepoint Ops LLC | $24974280 | 117831 | 0.19% | शेयर |
| Gotham Asset Management, LLC | $24911119 | 117533 | 0.19% | शेयर |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $24607896 | 116373 | 0.19% | शेयर |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24569456 | 115921 | 0.19% | शेयर |
| Robeco Institutional Asset Management B.V. | $23854123 | 112546 | 0.19% | शेयर |
| AEGON ASSET MANAGEMENT UK Plc | $22866862 | 107888 | 0.18% | शेयर |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $22670926 | 106964 | 0.18% | शेयर |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $22530921 | 106303 | 0.18% | शेयर |
| MERCER GLOBAL ADVISORS INC /ADV | $22106507 | 104301 | 0.17% | शेयर |
| Moran Wealth Management, LLC | $22053609 | 104051 | 0.17% | शेयर |
| ABN AMRO Bank N.V. | $21523733 | 101667 | 0.17% | शेयर |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $21496202 | 123876 | 0.17% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21322170 | 100600 | 0.17% | कॉल ऑप्शन |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21146252 | 99770 | 0.16% | शेयर |
| AVIVA PLC | $20378569 | 96148 | 0.16% | शेयर |
| SCHWARTZ INVESTMENT COUNSEL INC | $20326005 | 95900 | 0.16% | शेयर |
| Boston Common Asset Management, LLC | $20282767 | 95696 | 0.16% | शेयर |
| CAPTRUST FINANCIAL ADVISORS | $20146790 | 95054 | 0.16% | शेयर |
| Midwest Trust Co | $20113207 | 94896 | 0.16% | शेयर |
| LAZARD ASSET MANAGEMENT LLC | $20035210 | 94528 | 0.16% | शेयर |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $19842759 | 93620 | 0.15% | शेयर |
| BLAIR WILLIAM & CO/IL | $19773115 | 93291 | 0.15% | शेयर |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $19613005 | 92536 | 0.15% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19160280 | 90400 | 0.15% | पुट ऑप्शन |
| CITADEL ADVISORS LLC | $18821160 | 88800 | 0.15% | कॉल ऑप्शन |
| WELLINGTON MANAGEMENT GROUP LLP | $17507282 | 82601 | 0.14% | शेयर |
| Foundry Partners, LLC | $17338432 | 102473 | 0.13% | शेयर |
| MARSHALL WACE, LLP | $17187874 | 81094 | 0.13% | शेयर |
| Coho Partners, Ltd. | $16981317 | 89103 | 0.13% | शेयर |
| Copeland Capital Management, LLC | $16902800 | 79749 | 0.13% | शेयर |
| CIBC Asset Management Inc | $16674318 | 78671 | 0.13% | शेयर |
| Mitsubishi UFJ Trust & Banking Corp | $16558594 | 78125 | 0.13% | शेयर |
कंपनी के अंदरूनी सूत्र 53 इनसाइडर्स · 26 अधिकारी · 26 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| E. J. Davis | CEO and President | 1 जून 2026 S | 132423 | 0 | 5 | $-14656302 |
| Surya N Mohapatra | Chairman, President & CEO | 30 अप्रैल 2012 F | 243713 | 0 | 0 | $0 |
| Sam Samad | Executive Vice President & CFO | 22 जुलाई 2026 A | 33478 | 0 | 0 | $0 |
| Mark Guinan | Executive Vice President & CFO | 7 मार्च 2022 F | 98981 | 0 | 0 | $0 |
| Robert Hagemann | SVP & Chief Financial Officer | 5 मार्च 2013 F | 126722 | 0 | 0 | $0 |
| Mark E Delaney | SVP & Chief Commercial Officer | 28 जुलाई 2026 S | 10335 | 0 | 1 | $-376288 |
| Karthik Kuppusamy | SVP, Clinical Solutions | 22 जुलाई 2026 L | 13557 | 0 | 2 | $-2167772 |
| Patrick Plewman | SVP for Diagnostic Services | 22 जुलाई 2026 L | 15293 | 0 | 4 | $-2194322 |
| Catherine T. Doherty | EVP, Regional Businesses | 5 मार्च 2026 S | 67122 | 0 | 7 | $-6671228 |
| Michael E Prevoznik | SVP & General Counsel | 5 मार्च 2026 S | 37557 | 0 | 7 | $-6505199 |
| Michael J Deppe | SVP, Corp. Controller & CAO | 4 मार्च 2026 F | 35196 | 0 | 0 | $0 |
| Mark A Gardner | SVP of Molecular Gen & Oncol | 24 सितमबर 2024 F | 4673 | 0 | 0 | $0 |
| Manner Carrie Eglinton | SVP, Advanced Diagnostics | 7 मार्च 2022 F | 48391 | 0 | 0 | $0 |
| Manuel O. Mendez | SVP & Chief Commercial Officer | 17 फ़रवरी 2021 A | 29045 | 0 | 0 | $0 |
| Robert A Klug | VP, Corporate Controller | 1 मार्च 2019 F | 6261 | 0 | 0 | $0 |
| Jon R Cohen | SVP & Group Exec. Diag. Sol. | 8 मार्च 2018 M | 31757 | 0 | 0 | $0 |
| Everett Cunningham | SVP, Commercial | 1 मार्च 2018 G | 37760 | 0 | 0 | $0 |
| Thomas F Bongiorno | VP and Corporate Controller | 2 मार्च 2015 F | 11837 | 0 | 0 | $0 |
| John B. Haydon | SVP, Operations | 13 फ़रवरी 2014 A | 19890 | 0 | 0 | $0 |
| Kathy Ordonez | SVP, Diagnostic Solutions | 31 मार्च 2013 F | 9569 | 0 | 0 | $0 |
| Joan Elizabeth Miller | SVP-Oncology & Neurology Srvcs | 29 फ़रवरी 2012 F | 89232 | 0 | 0 | $0 |
| Wayne R. Simmons | Vice President, Operations | 16 जून 2011 M | 47150 | 0 | 0 | $0 |
| Robert E Peters | VP, Sales & Marketing | 12 फ़रवरी 2007 A | 12974 | 0 | 0 | $0 |
| David M Zewe | SVP, Diagnostic Testing Ops | 12 फ़रवरी 2007 A | 31079 | 0 | 0 | $0 |
| GRANT THOMAS W II | Sr VP, Ins. & Employer Serv. | 12 फ़रवरी 2007 A | — | 0 | 0 | $0 |
| Gerald C Marrone | SVP, Administration | 28 फ़रवरी 2004 F | 49609 | 0 | 0 | $0 |
| Wright Lassiter III | निदेशक | 22 जुलाई 2026 L | 10323 | 0 | 0 | $0 |
| Vicky B Gregg | निदेशक | 22 जुलाई 2026 A | 18386 | 0 | 1 | $-239700 |
| Robert B Carter | निदेशक | 22 जुलाई 2026 L | 3864 | 0 | 0 | $0 |
| Timothy L Main | निदेशक | 22 जुलाई 2026 L | 22460 | 0 | 0 | $0 |
| Timothy C Wentworth | निदेशक | 1 जुलाई 2026 A | 1358 | 0 | 0 | $0 |
| Timothy M Ring | निदेशक | 20 मई 2026 A | 31140 | 0 | 0 | $0 |
| Gary M Pfeiffer | निदेशक | 20 मई 2026 A | 31005 | 0 | 1 | $-270317 |
| Luis Diaz | निदेशक | 15 मई 2025 A | 4054 | 0 | 0 | $0 |
| Tracey Doi | निदेशक | 15 मई 2025 A | 6490 | 0 | 0 | $0 |
| Gail R Wilensky | निदेशक | 17 मई 2023 A | 20506 | 0 | 0 | $0 |
| Stephen H Rusckowski | निदेशक | 6 मार्च 2023 F | 389597 | 0 | 0 | $0 |
| Helen Torley | निदेशक | 25 मई 2021 A | 6260 | 0 | 0 | $0 |
| Daniel Stanzione | निदेशक | 23 नवमबर 2020 S | 28349 | 0 | 0 | $0 |
| Jenne K Britell | निदेशक | 4 जून 2018 G | 14479 | 0 | 0 | $0 |
| Jeffrey M Leiden | निदेशक | 29 मई 2018 S | 6000 | 0 | 0 | $0 |
| John B Ziegler | निदेशक | 22 फ़रवरी 2017 S | 16557 | 0 | 0 | $0 |
| John C Baldwin MD | निदेशक | 12 अगस्त 2015 S | 12949 | 0 | 0 | $0 |
| William F Buehler | निदेशक | 12 फ़रवरी 2014 M | 26225 | 0 | 0 | $0 |
| GSK plc | निदेशक | 31 जनवरी 2011 S | 0 | 0 | 0 | $0 |
| Rosanne Haggerty | निदेशक | 6 मई 2010 A | 9334 | 0 | 0 | $0 |
| William R Grant | निदेशक | 1 अप्रैल 2007 A | 3334 | 0 | 0 | $0 |
| James F Flaherty III | निदेशक | 4 मई 2006 A | 1667 | 0 | 0 | $0 |
| Kenneth D Brody | निदेशक | 28 अप्रैल 2004 S | 0 | 0 | 0 | $0 |
| Mary A Cirillo | निदेशक | 1 अप्रैल 2004 A | 2627 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 13 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated | 18 मई 2011 | — | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 1 फ़रवरी 2011 | — | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 20 मार्च 2009 | — | प्रारंभिक फाइलिंग | — | SEC |
| GlaxoSmithKline plc ×2 फाइलिंग | 18 सितमबर 2008 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 16 फ़रवरी 2007 | — | प्रारंभिक फाइलिंग | — | SEC |
| Quest Diagnostics Incorporated - (FEIN No. ×2 फाइलिंग | 19 जनवरी 2006 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 15 दिसमबर 2004 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 29 जून 2004 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 24 जून 2002 | — | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 22 मई 2002 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 12 अप्रैल 2002 | — | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| IRS Identification Nos. of Above Persons (entities only) Quest Diagnostics Ventures LLC - (FEIN No., Quest Diagnostics Incorporated - (FEIN No. ×3 फाइलिंग | 1 नवमबर 2001 | — | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 14 मई 2001 | — | प्रारंभिक फाइलिंग | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 192 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IHF · iShares Trust | 3.93% | 199039 SH | 21 अगस्त 2026 | दैनिक |
| FTDS · First Trust Exchange-Traded Fund | 2.17% | 3760 NS | 30 जून 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.71% | 58159 SH | 21 अगस्त 2026 | दैनिक |
| GK · AdvisorShares Trust | 1.43% | 2156 NS | 30 जून 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.29% | 57932 NS | 30 अप्रैल 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1.24% | 9488 SH | 21 अगस्त 2026 | दैनिक |
| TMFX · RBB Fund, Inc. | 1.05% | 1724 NS | 31 मई 2026 | N-PORT |
| ANEW · ProShares Trust | 0.92% | 364 NS | 31 मई 2026 | N-PORT |
| QLTY · GMO ETF Trust | 0.85% | 196208 NS | 31 मई 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 0.82% | 4047 NS | 30 अप्रैल 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.80% | 635 NS | 30 अप्रैल 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0.78% | 4426 SH | 21 अगस्त 2026 | दैनिक |
| QLV · FlexShares Trust | 0.74% | 6461 NS | 30 अप्रैल 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 0.72% | 741 NS | 31 मई 2026 | N-PORT |
| ESMV · iShares Trust | 0.72% | 236 SH | 21 अगस्त 2026 | दैनिक |
| PAPI · Morgan Stanley ETF Trust | 0.56% | 10542 NS | 30 जून 2026 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0.52% | 1956 NS | 30 अप्रैल 2026 | N-PORT |
| PRAY · FIS Trust | 0.47% | 1958 NS | 31 मई 2026 | N-PORT |
| ITAN · EA Series Trust | 0.46% | 2110 NS | 29 मई 2026 | N-PORT |
| BTAL · AGF Investments Trust | 0.46% | 6072 NS | 30 जून 2026 | N-PORT |
| KNGZ · First Trust Exchange-Traded Fund VI | 0.44% | 1301 NS | 30 जून 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0.44% | 1055 NS | 30 अप्रैल 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0.44% | 409814 NS | 30 अप्रैल 2026 | N-PORT |
| FVD · First Trust Exchange-Traded Fund | 0.43% | 161912 NS | 30 जून 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0.41% | 3999 NS | 31 मई 2026 | N-PORT |
| IYH · iShares Trust | 0.41% | 65931 SH | 21 अगस्त 2026 | दैनिक |
| VOE · VANGUARD INDEX FUNDS | 0.40% | 711079 SH | 19 अगस्त 2026 | दैनिक |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.38% | 8682 NS | 30 अप्रैल 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.37% | 8368 NS | 30 अप्रैल 2026 | N-PORT |
| IMCV · iShares Trust | 0.37% | 18030 SH | 21 अगस्त 2026 | दैनिक |
| SUSA · iShares Trust | 0.35% | 59963 SH | 21 अगस्त 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.35% | 51278 NS | 30 अप्रैल 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0.34% | 23030 NS | 30 अप्रैल 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.34% | 330273 SH | 19 अगस्त 2026 | दैनिक |
| IXJ · iShares Trust | 0.32% | 58047 SH | 21 अगस्त 2026 | दैनिक |
| RXL · ProShares Trust | 0.31% | 1147 NS | 31 मई 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.31% | 2194 NS | 30 अप्रैल 2026 | N-PORT |
| GNOM · Global X Funds | 0.28% | 789 NS | 31 मई 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0.26% | 79983 NS | 30 अप्रैल 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.26% | 7703000 | 19 अगस्त 2026 | दैनिक |
| IWS · iShares Trust | 0.25% | 166379 SH | 21 अगस्त 2026 | दैनिक |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.24% | 18806 NS | 30 अप्रैल 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.24% | 8995 NS | 30 अप्रैल 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0.23% | 3340 NS | 30 अप्रैल 2026 | N-PORT |
| CVMC · Morgan Stanley ETF Trust | 0.23% | 1137 NS | 30 जून 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.23% | 26229 NS | 30 अप्रैल 2026 | N-PORT |
| SIZE · iShares Trust | 0.23% | 4242 SH | 21 अगस्त 2026 | दैनिक |
| DFVE · DoubleLine ETF Trust | 0.23% | 351 NS | 30 जून 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.23% | 2398948 SH | 19 अगस्त 2026 | दैनिक |
| EUSA · iShares, Inc. | 0.22% | 18045 SH | 21 अगस्त 2026 | दैनिक |